Antiviral drug remdesivir shows promise in trial on monkeys with coronavirus

US government scientists reported that the antiviral drug remdesivir has been effective in treating monkeys infected with COVID-19.

“Early treatment with the experimental antiviral drug remdesivir significantly reduced clinical disease and damage to the lungs of rhesus macaques infected with SARS-CoV-2, the coronavirus that causes COVID-19,” said a press release from the National Institutes of Health, which ran the experiment.

The small study, which is preliminary and has yet to be peer-reviewed, mimicked treatment procedures that are being used in a large human trial conducted on patients who have been hospitalized with either the COVID-19 disease or the SARS-CoV-2 virus.

Remdesivir works against the COVID-19 by adding mutations that ultimately destroy the virus.

What's happening in Tunisia?
Subscribe to our Youtube channel for updates.

Top 48h

Copyright © 2019 Tunisie Numerique

To Top